Is Durect Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: DRRX) stock is to Strong Buy DRRX stock.
Out of 3 analysts, 2 (66.67%) are recommending DRRX as a Strong Buy, 1 (33.33%) are recommending DRRX as a Buy, 0 (0%) are recommending DRRX as a Hold, 0 (0%) are recommending DRRX as a Sell, and 0 (0%) are recommending DRRX as a Strong Sell.
What is DRRX's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: DRRX) forecast ROE is N/A, which is considered weak.
What is DRRX's Price Target?
According to 3 Wall Street analysts that have issued a 1 year DRRX price target, the average DRRX price target is $37.67, with the highest DRRX stock price forecast at $44.00 and the lowest DRRX stock price forecast at $32.00.
On average, Wall Street analysts predict that Durect's share price could reach $37.67 by May 17, 2024. The average Durect stock price prediction forecasts a potential upside of 554.51% from the current DRRX share price of $5.76.
What is DRRX's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: DRRX) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.03%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.